Osteoarthritis is the most prevalent rheumatic disease in the elderly population. Although it is not fatal, it significantly impacts the quality of life of those who suffer from it. According to the EPISER2016 study, conducted by the Spanish Society of Rheumatology, 29.3% of the population over 40 years of age presents joint changes compatible with osteoarthritis in some of their joints. OA is the leading cause of disability in Spain, 80% of people with OA have movement restrictions and 25% are unable to perform some activities of daily living. Moreover, 11% of adults with OA need help with personal care and 14% need help with daily living needs. Furthermore, osteoarthritis has a high economic cost for the National Health System. The ArtRoCad study (carried out in 2007) estimated the cost of these pathologies for the entire year 2007 at 4,738 million euros, equivalent to 0.5% of the Spanish GDP. However, taking into account the gradual increase in life expectancy and the obesity epidemic, the number of patients with osteoarthritis is expected to double in the next 30 years and, therefore, the costs will increase exponentially. However, the process of diagnosing early osteoarthritis and the therapeutic options for these patients still have significant limitations.
Advances in molecular biology and technological development are allowing personalised and precision medicine to become a reality in everyday clinical practice in some areas. This personalised and precision medicine can undoubtedly help find answers to two of the main problems currently faced by OA patients: early diagnosis of the disease and treatment of joint deterioration.
With the aim of analysing the current situation of personalised and precision medicine in knee osteoarthritis, a symposium will be held in A Coruña on 23 and 24 June 2023. This symposium is organised by the Spanish Society of Rheumatology (SER), a scientific association that aims to foster knowledge of rheumatic pathologies by encouraging medical training, developing research studies in Rheumatology and promoting the dissemination and knowledge of these conditions among the general population; together with the Osteoarthritis Research Society International (OARSI), the leading international organisation of scientists and health professionals focused on the prevention and treatment of osteoarthritis through the promotion and presentation of research, education and the worldwide dissemination of new knowledge.
The symposium will bring together leading experts in OA and personalised medicine from around the world. The organisers and experts hope this symposium will help professionals working with OA patients learn more about all the possibilities that precision medicine can offer them.
Dr Francisco J. Blanco
Scientific Organising Committee of the Symposium
For the presentation of the different talks of the Symposium, the speakers will be able to download an Office template with the official image of the meeting.
You will be able to upload the presentations in the Speakers Area located in the exhibition area.
Francisco J Blanco
Complexo Hospitalario Universitario A Coruña, Spain
Centro Médico Teknon, Barcelona, Spain
Integrative Research Institute for Regenerative Biomedical Engineering, Dongguk University, South Korea
Hospital Universitari Parc Taulí, Barcelona, Spain
Cristina Ruiz Romero
Complexo Hospitalario Universitario A Coruña, Spain
- Your abstract must be submitted via email at email@example.com before 28 May
- This submission must include your work attached, and the following mandatory fields:
- Abstract title
- Body (up to 3.500 characters)
- Corresponding author
- Corresponding e-mail
- A confirmation e-mail will be sent to your e-mail address.
- 5 projects will be selected as oral communications to be presented in SESSION 4 of the Scientific Programme. The remaining abstracs will be presented as posters in the exhibition area.
- The final evaluation will be communicated to the corresponding author after 29 May.
- In the body of the abstract, the character limit is set at 3,500 characters, including text spaces (tables/images are excluded from this character limit).
- Optionally, you may include a maximum of three images (*.jpg and *.png formats) with a maximum file size of 5MB and a resolution of at least 300 dpi. It will be necessary to include a “reference” in the body text of the abstract that refers to the image/graphic. E.g. (image 1, graphic 1, etc.).
Please note that the deadline for submission is 21 May 2023, at 23.59h (UTC+2).
For any assistance regarding your submission, please contact firstname.lastname@example.org.
- Individual registration for the Symposium via this link.
- Individual registration for the Gala Dinner via this link.
- Group registration via this link.
|MD, Professor, PhD, lab director||200 €||250 €|
|Postdoc, Student, Resident, Felow, Nurse, etc.||100 €||150 €|
|Gala dinner||100 €|
The fee includes:
- Free access to scientific sessions
- Certificate of attendance
- Coffee breaks
- Working lunch
*Airfare and accommodation are not included.
- For security reasons, non-accredited people will not be allowed access.
- Registrations are non-refundable.
- For any information regarding registration for this Congress, please send an e-mail to: email@example.com.
For any information regarding accommodation at Hotel Attica21 Coruña, please contact firstname.lastname@example.org.